Emmaus Life Sciences, Inc.

EMMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13D/A Feb 17, 2022 AMENDMENT NO. 4 TO SCHEDULE 13D
4 Feb 16, 2022 FORM 4 SUBMISSION
4 Feb 11, 2022 FORM 4 SUBMISSION
4 Feb 9, 2022 FORM 4 SUBMISSION
4 Feb 7, 2022 FORM 4 SUBMISSION
3 Jan 24, 2022 FORM 3 SUBMISSION
8-K Jan 10, 2022 CURRENT REPORT
4 Jan 5, 2022 FORM 4 SUBMISSION
4 Jan 5, 2022 FORM 4 SUBMISSION
4 Jan 3, 2022 FORM 4 SUBMISSION
S-8 Dec 30, 2021 REGISTRATION STATEMENT
3 Dec 28, 2021 FORM 3 SUBMISSION
4 Dec 28, 2021 FORM 4 SUBMISSION
4 Dec 22, 2021 FORM 4 SUBMISSION
3 Dec 20, 2021 FORM 3 SUBMISSION
4 Dec 17, 2021 FORM 4 SUBMISSION
4 Dec 10, 2021 FORM 4 SUBMISSION
4 Dec 6, 2021 FORM 4 SUBMISSION
4 Dec 2, 2021 FORM 4 SUBMISSION
SC 13D/A Dec 1, 2021 AMENDMENT NO. 3 TO SCHEDULE 13D
3 Nov 30, 2021 FORM 3 SUBMISSION
4 Nov 30, 2021 FORM 4 SUBMISSION
4 Nov 30, 2021 FORM 4 SUBMISSION
8-K Nov 29, 2021 CURRENT REPORT
4 Nov 26, 2021 FORM 4 SUBMISSION
← Newer Page 6 of 50 · 1238 filings Older →